that’s set to detect pathogens such as E.Coli and all the others that cause illness from eating infected
food preparations. Thanks Travis.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
LXG.v lxxgf
What are the answers to this 5?
Un is a $28 million options trade signaling a major consolidation in the transportation sector.
Deux is betting $2.19 million on Warren Buffett’s next major acquisition.
Trois is hinting at a $5 million play on what we believe could be Verizon’s next buyout.
Quatre is banking $877,600 on a behind-the-scenes tech company sparking a major bidding war between industry leaders.
Cinq is cashing in on the next big merger in the casino and gaming industry.
#b2yaz backoffice and Gummunity
We covered that one here: https://www.stockgumshoe.com/reviews/alternative-energy-speculator/hodges-new-fda-mandate-sends-this-device-into-every-restaurant-in-america/
As to the “in every restaurant come November” bit, that’s balderdash even in the big picture. Food testing requirements may become more stringent, but every restaurant will not have a microfluidic pathogen detection device, and every plate of food will not be tested. That’s just dumb.
And in the small picture, the balderdashery is more intense — this particular company has a pre-prototype, and they hope to be testing their actual prototype around now, with testing expected to be completed by November. Of the prototype. This is nowhere near being a mass production device — so far they have built that “pre-prototype” that they presented in their booth at a conference in July, that’s all.